Total Stock Market ETF Vanguard (VTI) 103.83 $VTI The

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Total Stock Market ETF Vanguard (VTI) 103.83 $VTI

The SPDR ETF: Buy the S&P 500 for a Bargain Price
Selena Maranjian, The Motley Fool - Motley Fool - 8 mins ago
This SPDR ETF can instantly have you invested in about 80% of the U.S. stock market. Photo:  TaxCredits.net . With more than 3,000 different stocks and roughly 8,000 mutual funds to invest in, it's not easy to decide where to put your money. To...
VTI: 103.83 (+0.14), VT: 58.83 (+0.09), SPY: 201.33 (+0.12)

Look for Shares of Vanguard Total Stock Market ETF to Potentially Pullback after Yesterday's 1.46% Rise
Comtex SmarTrend(R) - Fri Oct 02, 4:30PM CDT
Vanguard Total Stock Market ETF (AMEX:VTI) traded in a range yesterday that spanned from a low of $97.38 to a high of $100.37. Yesterday, the shares gained 1.5%, which took the trading range above the 3-day high of $99.12 on volume of 3.6 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
VTI: 103.83 (+0.14)

SmarTrend Watching for Potential Pullback in Shares of Vanguard Total Stock Market ETF After 1.46% Gain
Comtex SmarTrend(R) - Fri Oct 02, 4:30PM CDT
Vanguard Total Stock Market ETF (AMEX:VTI) traded in a range yesterday that spanned from a low of $97.38 to a high of $100.37. Yesterday, the shares gained 1.5%, which took the trading range above the 3-day high of $99.12 on volume of 3.6 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
VTI: 103.83 (+0.14)

SmarTrend Watching for Potential Rebound in Shares of Vanguard Total Stock Market ETF After 2.68% Loss
Comtex SmarTrend(R) - Mon Sep 28, 4:28PM CDT
Vanguard Total Stock Market ETF (AMEX:VTI) traded in a range yesterday that spanned from a low of $96.80 to a high of $99.13. Yesterday, the shares fell 2.7%, which took the trading range below the 3-day low of $99.07 on volume of 5.6 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
VTI: 103.83 (+0.14)

5 Smart Beta ETFs to Beat the Choppy Market
Sweta Killa - Zacks Investment Research - Wed Sep 23, 9:15AM CDT
Smart beta ETFs offer best of both active and passive strategies, providing investors an opportunity to increase portfolio diversification, reduce risk, and enhance returns.
IJT: 126.76 (+0.37), VTI: 103.83 (+0.14), FVD: 23.74 (-0.05), IJR: 112.91 (+0.15), SPY: 201.33 (+0.12), FBT: 102.26 (+1.35), QUAL: 63.15 (+0.05), FDN: 70.31 (+0.33), FV: 22.65 (+0.17), USMV: 41.08 (+0.08), FXH: 59.12 (+0.53), SDY: 75.65 (-0.13), RZG: 85.55 (+0.26)

Vanguard Total Stock Market ETF Set to Possibly Rebound After Yesterday's Selloff of 1.34%
Comtex SmarTrend(R) - Tue Sep 22, 4:47PM CDT
Vanguard Total Stock Market ETF (AMEX:VTI) traded in a range yesterday that spanned from a low of $100.21 to a high of $101.24. Yesterday, the shares fell 1.3%, which took the trading range below the 3-day low of $101.59 on volume of 3.0 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
VTI: 103.83 (+0.14)

10 Twitter Feeds Investors Need to Follow
Ryan McQueeney - Zacks Investment Research - Tue Sep 22, 4:08PM CDT
The social media world can be a valuable tool for investors, and we show you the best profiles to follow on Twitter.
VTI: 103.83 (+0.14), SPY: 201.33 (+0.12), QQQ: 106.53 (+0.48), DIA: 170.76 (+0.39), IWM: 115.74 (+0.23), TWTR: 30.85 (+0.53)

Vanguard Total Stock Market ETF Rises 1.26% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Tue Sep 15, 5:12PM CDT
Vanguard Total Stock Market ETF (AMEX:VTI) traded in a range yesterday that spanned from a low of $101.53 to a high of $102.97. Yesterday, the shares gained 1.3%, which took the trading range above the 3-day high of $102.07 on volume of 2.4 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
VTI: 103.83 (+0.14)

Watch for Vanguard Total Stock Market ETF to Potentially Pullback After Gaining 1.26% Yesterday
Comtex SmarTrend(R) - Tue Sep 15, 5:11PM CDT
Vanguard Total Stock Market ETF (AMEX:VTI) traded in a range yesterday that spanned from a low of $101.53 to a high of $102.97. Yesterday, the shares gained 1.3%, which took the trading range above the 3-day high of $102.07 on volume of 2.4 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
VTI: 103.83 (+0.14)

The Famous 4% Rule Can Doom Your Retirement
Selena Maranjian, The Motley Fool - Motley Fool - Sat Sep 05, 6:08AM CDT
The rate at which you withdraw money from your nest egg is critical to a successful retirement. Photo: TaxCredits.net via Flickr. In the confusing world of personal finance, the 4% rule is refreshingly straightforward. This quick and easy formula...
VTI: 103.83 (+0.14), VT: 58.83 (+0.09), SPY: 201.33 (+0.12)

6 ETFs to Watch in September
Zacks Equity Research - Zacks Investment Research - Thu Sep 03, 11:52AM CDT
Investors can look at the near-term outlook of these investing areas and the related ETFs in September after experiencing a horrible August.
VTI: 103.83 (+0.14), USO: 15.99 (-0.05), CNXT: 36.50 (-0.14), PSCC: 57.18 (+0.41), EDV: 117.10 (+0.21), XME: 19.77 (+0.17)

Look for Shares of Vanguard Total Stock Market ETF to Potentially Rebound after Yesterday's 2.94% Sell Off
Comtex SmarTrend(R) - Tue Sep 01, 4:12PM CDT
Vanguard Total Stock Market ETF (AMEX:VTI) traded in a range yesterday that spanned from a low of $98.75 to a high of $100.83. Yesterday, the shares fell 2.9%, which took the trading range below the 3-day low of $100.92 on volume of 9.2 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
VTI: 103.83 (+0.14)

Vanguard Total Stock Market ETF Falls 2.94% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Tue Sep 01, 4:12PM CDT
Vanguard Total Stock Market ETF (AMEX:VTI) traded in a range yesterday that spanned from a low of $98.75 to a high of $100.83. Yesterday, the shares fell 2.9%, which took the trading range below the 3-day low of $100.92 on volume of 9.2 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
VTI: 103.83 (+0.14)

August ETF Asset Flow Roundup: Treasury Gains, EM Lags
Sweta Killa - Zacks Investment Research - Tue Sep 01, 8:30AM CDT
August was wild and volatile for the U.S. stock market, and all categories of the ETF investing world behaved indifferently last month.
VTI: 103.83 (+0.14), EEM: 35.94 (+0.13), VOO: 184.58 (+0.10), IEI: 124.33 (-0.05), VWO: 36.02 (+0.04), SHY: 84.96 (unch), EMB: 108.54 (+0.45), BIL: 45.69 (unch), USMV: 41.08 (+0.08)

Look for Shares of Vanguard Total Stock Market ETF to Potentially Rebound after Yesterday's 4.02% Sell Off
Comtex SmarTrend(R) - Mon Aug 24, 4:50PM CDT
Vanguard Total Stock Market ETF (AMEX:VTI) traded in a range yesterday that spanned from a low of $93.00 to a high of $101.27. Yesterday, the shares fell 4.0%, which took the trading range below the 3-day low of $102.18 on volume of 18.1 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
VTI: 103.83 (+0.14)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Savvas Launches Miller & Levine Biology Program Revamp

Updated Category News Views 35

Education Meets Innovation: Savvas Takes a Bold Step Who would have thought biology education could get a makeover that might actually stick? Savvas Learning Company thinks it's onto something with the launch of the all-new Miller & Levine Experience Biology Program. The spotlight's on innovation—it's about time someone shook up the way high schoolers learn biology. A...

Continue Reading
Factory-Built Homes Take Center Stage in New Doc Short

Updated Category News Views 88

Housing is one of those things we all think we understand until we start peeling back the layers of its history, especially when factory-built homes are involved. Here's a new angle: Clayton has just released the teaser for their documentary short, "Built: A Story of Factory-Built Housing in America," and it's turning the lights on a sector that's often left in the...

Continue Reading
transcosmos: Not Just Calls—Evolving Business Strategy

Updated Category News Views 110

Turning Talk into Triumphs Award chatter isn't exactly rare in this industry, but the latest accolades rolling in for transcosmos from the Best Contact Center Indonesia 2026 ain't your run-of-the-mill pat on the back. Sure, a trophy's a trophy, but when they snatch Gold in the Business Contribution category and another shiny Silver in People Development, it’s hinting at...

Continue Reading
Unicycive Faces Legal Heat: Shareholder Lawsuit Looms

Updated Category News Views 104

The Unicycive Landslide: What Went Down? Investors, buckle up. Unicycive Therapeutics Inc. (NASDAQ: UNCY) finds itself deep in the muck of a securities class action. Chief honchos, CEO Shalabh Gupta and CFO John Townsend, are taking the heat for allegedly controlling company disclosures that led shareholders to believe in non-existent progress with their third-party...

Continue Reading
SoftwareOne Triumphs in 2026 GitHub Partner Awards

Updated Category News Views 43

SoftwareOne Nabs Prestigious GitHub Honor Outta nowhere, SoftwareOne's been lashed onto the center stage, bagging GitHub's Global Channel Sales Partner of the Year for 2026. This ain't just another shiny trophy on the shelf; it's a solid nod to their grit and strategy. Now, if good old GitHub says you're their top dog, you're obviously doing something right. Not bad for a...

Continue Reading
Data Centers Drive Surge in Power and Cooling Demand

Updated Category News Views 23

Data Centers: The Unseen Powerhouses Don't let the tech jargon fool you—data centers are more than just server rooms. They're beastly energy guzzlers, and their demand is rippling through the supply chain in a big way. You've got companies like Vertiv, American Tower, Johnson Controls, and Generac riding high on this trend, making some serious waves in their quarterly...

Continue Reading
Data Breach at Lumara Bio: Privacy Lawsuits Loom

Updated Category News Views 28

Another Day, Another Data Breach It seems like you can’t throw a stone without hitting a data breach these days—and this time, it’s Lumara Bio USA’s turn under the spotlight. The Princeton-based oncology therapeutics outfit, part of Germany’s ITM Isotope Technologies, spilled some beans it never meant to. We're talking some pretty sensitive stuff here, folks....

Continue Reading
Jacobi's Harness Brings AI from Concept to Reality

Updated Category News Views 160

The Challenge of Moving AI to Production Diving headfirst into AI in finance? Well, Jacobi's bold move with their new toy, the Investment Management Harness, spotlights a filthy secret: the hurdles between a big idea and execution are seldom technological. We got AI shaving prototyping time down to just days, yet pushing to production? That's a marathon in itself. Boards...

Continue Reading
Air Canada-CAE Scholarship Drives Women in Aviation

Updated Category News Views 88

A New Chapter for Women in Aviation Call it paving the skies or busting the glass cockpit ceiling, but Air Canada and CAE are really doubling down on getting more women into aviation. They're rolling out the eighth annual Captain Judy Cameron Scholarship, set to open applications on November 1, 2026. With up to eight scholarships on the table for Canadian women eyeing...

Continue Reading
H.R. 10549: Hope Charities Pushes for Pharmacy Freedom

Updated Category News Views 63

Hope Charities Takes a Stand for Patients In Prairieville, Hope Charities is throwing its weight behind a bill they believe is brewing up a patient revolution. The Patients Choice in Specialty Pharmacy Act, otherwise known as H.R. 10549, sparked by Representatives Neal Dunn and Joe Wilson, tackles the comfortable partnerships some insurers have been enjoying with their...

Continue Reading

Top 5 Most Recently Viewed Articles

Innovative AI Assistant by ClickBid Revolutionizes Fundraising

Updated Category News Views 155

ClickBid Introduces Groundbreaking AI Assistant ClickBid, recognized as a pioneer in event fundraising technology, proudly presents ClickBid Search. This is the first custom GPT-powered AI assistant tailored specifically for nonprofits, designed to offer immediate and relevant answers to help organizations optimize their event strategies. Available at no cost to all...

Continue Reading
TIER IV and TUM Drive Level 4 Autonomous Cars

Updated Category News Views 25

Autonomous Driving Gets a German Boost Well folks, looks like the autonomous vehicle scene is hitting the autobahns with more horsepower than ever before. Today’s chatter is all about how TIER IV and the Technical University of Munich (TUM) have teamed up, tapping into the grid as they ride the waves of cutting-edge NVIDIA tech. The Sparks Under the Hood: NVIDIA...

Continue Reading
Vericel Corporation's Upcoming Presentation at MedTech Conference

Updated Category News Views 147

Vericel Corporation's Engagement at the MedTech Conference CAMBRIDGE, Mass. — Vericel Corporation (NASDAQ:VCEL), a recognized leader in advanced therapies for sports medicine and severe burn care, has exciting news regarding its participation at the upcoming Truist Securities MedTech Conference. The company will be featured in a fireside chat, slated to take place at...

Continue Reading
Gildan Achieves Strong Q2 Results: Revenue and Finances Surge

Updated Category News Views 128

Gildan Reports Remarkable Growth in Second Quarter Earnings Gildan Activewear Inc. (NYSE: GIL, TSX: GIL) has achieved record net sales of $919 million during the second quarter, reflecting a strong 6.5% increase compared to the previous year. Strong Operational Performance and Profitability This quarter's operating margin stood at an impressive 21.7%, with an adjusted...

Continue Reading
MimiVax and UI Pharmaceuticals Mark Key Production Milestone

Updated Category News Views 260

MimiVax and UI Pharmaceuticals Mark Key Production Milestone MimiVax and UI Pharmaceuticals have achieved an exciting development in the field of cancer treatment with the clinical manufacture of SurVaxM, an innovative immunotherapeutic vaccine aimed at targeting glioblastoma. SurVaxM proudly stands out as the first product to be manufactured at UI Pharmaceuticals' newly...

Continue Reading